Search
The National Venture Capital Association (“ NVCA”) has recently (but without any fanfare) released substantively important revisions to its model legal documents, specifically, the Investor Rights Agreement, the Stock Purchase Agreement, and the Certificate of Incorporation. These changes address...
On April 18, 2024, the Federal Trade Commission (FTC), U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human Services (HHS) collectively launched a new publicly accessible web portal to which members of the public can make reports of what they believe to be competition –...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the first quarter of 2024. If you would like to discuss...
Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the fourth quarter of 2023. If you would like to discuss...
On November 21, 2023, the Federal Trade Commission (FTC) approved a resolution allowing it to use “compulsory process in nonpublic investigations involving certain products and services that use or claim to be produced using artificial intelligence (AI) or claim to detect its use.” This allows the...
Overview (Program Summary) Alexander (Sandy) R. Bilus, Partner, Saul Ewing LLP, Cybersecurity and Privacy Co-Chair, will be the speaker. This session, sponsored by the Association of Corporate Counsel, will focus on the state privacy laws that are going into effect in 2023 as well as current...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
![Kathryn Doyle](/sites/default/files/styles/card_410x307_/public/images/2022-08/Doyle_Kathryn_LinkedIn.jpg?h=40c24adf&itok=CWxgEisc)
A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...
![Gianna Arnold Headshot](/sites/default/files/styles/card_410x307_/public/images/2022-08/Arnold_Gianna_LinkedIn.jpg?h=40c24adf&itok=xR0mzs02)
Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...
![George E. Rahn, Jr.](/sites/default/files/styles/card_410x307_/public/images/2022-08/Rahn_Ned_LinkedIn.jpg?h=40c24adf&itok=Jn4aJJIf)
George "Ned" Rahn focuses his practice on commercial litigation including national and international construction matters. He has handled matters for contractors, engineering firms, owners, and surety bond companies in a variety of contexts. Ned has dealt with matters for general contractors...
![Marshall B. Paul](/sites/default/files/styles/card_410x307_/public/images/2022-08/Paul_Marshall_LinkedIn.jpg?h=40c24adf&itok=XIX7s8UE)
Marshall Paul focuses his practice on counseling businesses, health care concerns and professionals with respect to limited liability company matters, general corporate matters, joint ventures, acquisitions and sales, fiduciary duty issues and financings. His clients include large-scale health care...
![Eric G. Orlinsky Headshot](/sites/default/files/styles/card_410x307_/public/images/2022-08/Orlinsky_Eric_LinkedIn.jpg?h=40c24adf&itok=dje76Rlz)
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...
![Charles O. Monk, II](/sites/default/files/styles/card_410x307_/public/images/2022-08/Monk_Charles_LinkedIn.jpg?h=40c24adf&itok=LWLm4j59)
Charlie Monk handles complex, high-stakes litigation. During his 40 years as a trial lawyer, clients ranging from governmental entities and security broker dealers to energy providers and utilities have relied on his legal counsel to help them deal with complex litigation. He has led teams dealing...
![John F. Stoviak](/sites/default/files/styles/card_410x307_/public/images/2022-08/Stoviak_John_LinkedIn.jpg?h=753774cc&itok=MUOXQ52d)
John Stoviak handles high-stakes litigation, complex trials and appeals for business, energy and environmental clients in courts throughout the United States, and he represents colleges, universities, and independent schools in delicate governance matters and issues. He has achieved two $100 million...
![Profile placeholder image - dark gray graphic silhouette over light gray background](/sites/default/files/styles/card_410x307_/public/images/2022-08/profile_placeholder_small.jpg?h=a7b36234&itok=cJK1OEOo)
Michael Petrizzo brings nearly 30 years of experience to his work guiding clients through mergers and acquisitions, financing transactions, and corporate formations, reorganizations and restructurings. Public and private companies, private equity and venture capital firms, and high-net-worth...